Dr Doug Kwon from Harvard Medical School discusses his research on how the vaginal microbiome affects HIV transmission in women around the world.

Dr James J. Matera from CentraState Medical Center in Freehold, New Jersey, discusses optimal blood pressure targets in patients with kidney disease, and how the 2017 hypertension guidelines issued by the American Heart Association and American College of Cardiology affect these targets.

Dr James J. Matera from CentraState Medical Center in Freehold, New Jersey, discusses optimal blood pressure targets in patients with kidney disease, and how the 2017 hypertension guidelines issued by the American Heart Association and American College of Cardiology affect these targets.

Dr James J. Matera from CentraState Medical Center in Freehold, New Jersey, discusses optimal blood pressure targets in patients with kidney disease, and how the 2017 hypertension guidelines issued by the American Heart Association and American College of Cardiology affect these targets.

In part 2 of this 4-part series, Dr Paul Mather from the Perelman School of Medicine talks about diagnosis, evaluation, and management of acute decompensated heart failure and chronic heart failure.

In part 2 of this 4-part series, Dr Paul Mather from the Perelman School of Medicine talks about diagnosis, evaluation, and management of acute decompensated heart failure and chronic heart failure.

In part 2 of this 4-part series, Dr Paul Mather from the Perelman School of Medicine talks about diagnosis, evaluation, and management of acute decompensated heart failure and chronic heart failure.

Dr Russell Cohen, recently spoke at the IBD Clinical Challenges and Emerging Therapies conference and discussed key takeaways from his session on JAK inhibitors and their role in clinical practice.

Dr Russell Cohen, recently spoke at the IBD Clinical Challenges and Emerging Therapies conference and discussed key takeaways from his session on JAK inhibitors and their role in clinical practice.

Dr Russell Cohen, recently spoke at the IBD Clinical Challenges and Emerging Therapies conference and discussed key takeaways from his session on JAK inhibitors and their role in clinical practice.